Rob Scott MD in

Rob Scott MD

Login to view DISC.
Chief Medical Officer & Head of R&D at ABIONYX Pharma
📍 Los Angeles Metropolitan Area, United States

Rob Scott is a seasoned pharmaceutical executive with nearly four decades of experience, currently serving as Head of R&D and CMO at ABIONYX Pharma. He has overseen the development of blockbuster drugs like Lipitor, Repatha, and Skyrizi. A University of Cape Town graduate, he sits on multiple biotech and venture capital boards.

His social media activity shows a strong interest in metabolic health, particularly the science behind LDL cholesterol management and the impact of diet on cardiovascular disease. He advocates for balanced, evidence-based health information over media fear-mongering and is described by colleagues as a visionary leader.

Unique fact: Born in Zimbabwe, he invented and developed Caduet, the first commercially available combination pill (Polypill) for cardiovascular disease.

Read the full overview →
Current Role
Chief Medical Officer & Head of R&D
Job Level
Leadership
Location
Los Angeles Metropolitan Area, United States
Personality Overview

How Rob shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Rob cares about

Cardiovascular Research
A core focus of his career, he has led development for major cardiovascular drugs like Lipitor and Repatha and served on the FDA's Cardiovascular and Renal Drug Advisory Committee.
Novel Drug Development
Actively shaping the future of medicine through board and advisory roles at multiple biotech firms focused on Sepsis, rare diseases, and targeted protein degradation.
+5 more topics Login to view topics
Career

Work history

1-2024
Chief Medical Officer & Head of R&D
ABIONYX Pharma
2022 - 12-2024
Board Member
Redx Pharma
1-2021
Board Member
OncoSpherix
2021 - 9-2024
Board Member
Windtree Therapeutics, Inc.
9-2020
Board Member
Draupnir Bio
In the press

Media appearances

ABIONYX Pharma appoints Rob Scott, MD, as Chief Medical Officer and Head of R&D. Featured in PharmiWeb
See now
ABIONYX Pharma annonce la nomination du Dr Rob Scott au poste de Chief Medical Officer et Head of R&D. Featured in Business Wire (French)
+3 more appearances Login to view media
Education
1977 - 1981
MbChB
University of Cape Town
1974 - 1976
BSc
University of Cape Town
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Rob. Free, 10 seconds.